Info: Zenodo’s user support line is staffed on regular business days between Dec 23 and Jan 5. Response times may be slightly longer than normal.

Published April 28, 2023 | Version v1
Journal article Open

Features of the Clinical Course and Quality of Life in a State with Chronic Pancreatitis and Gastroduodenal Changes

Creators

  • 1. I. Horbachevsky Ternopil National Medical University of Ministry of Health of Ukraine, Ukraine

Description

Despite the significant progress in the study of pancreatic gland (PG) pathology, the clinical symptoms and syndromes, as well as assessment of quality of life using the SF-36 and GSRS questionnaires in patients with chronic pancreatitis (CP) in combination with comorbid pathology of the organs of the gastroduodenal zone (GDZ) remain insufficiently studied and substantiated.

The objective: to analyze the clinical symptoms and assessment of quality of life using the SF 36 and GSRS questionnaires in the comorbidity of chronic pancreatitis with H. pylori-associated chronic gastritis.

Materials and methods. An examination and study of indicators of 30 outpatients with CP and 117 patients with CP in comorbidity with chronic gastritis (CG) associated with H. pylori was carried out. 87 (59.2%) men and 60 (40.8%) women from 19 to 76 years old (average age – 48.29±1.04 years) were the participants. The control group included 30 practically healthy persons, comparable in age and sex.

The clinical manifestations of the participants of the study groups were analyzed. For a reliable assessment of the quality of life, groups of patients were compared: the control group, patients with CP and patients with comorbidities. The physical and psychological components were evaluated using the SF-36 questionnaire. Indicators of the quality of life components of patients according to the scales of the GSRS questionnaire were also studied.

Results. Clinical symptomatology in the comorbidity of CP with concomitant gastroduodenal disorders had features compared to those in isolated CP. Painful, dyspeptic, enteropancreatic and asthenovegetative, anemic syndromes were more often detected in patients with CP and disorders of the gastrointestinal tract.

It was found that the average total score of the physical component in patients with CP and comorbidity was significantly lower than that in the group of isolated CP according to the SF-36 questionnaire: the difference between the values of the average total score of the physical component of quality of life in patients of the comparison groups was 10.42 points (11.2%).

Conclusions. The results of the study show that the difference between the total indicators of the scales of the psychological component of the quality of life according to the SF-36 questionnaire of the groups of patients with CP and patients with comorbidity is 9.71 (11.5%). This proves that the psychological state of patients with CP with accompanying gastroduodenal changes is significantly worse.

Files

Features_of_the_Clinical_Course_and_Quality_of_Life_in_a_State_with_Chronic_Pancreatitis_and_Gastroduodenal_Changes.pdf

Files (1.8 MB)

Additional details

References

  • Zhu X, Zhu C, Zhao Y, Liu X, Sa R, Wang Y, et al. Prevalence of Helicobacter pylori Virulence Genes and Their Association with Chronic Gastritis in Beijing, China. Curr Microbiol. 2022;80(1):33. doi: 10.1007/s00284-022-03135-6.
  • Hooi JKY, Lai WY, Ng WK, Suen MMY, Underwood FE, Tanyingoh D, et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420–9. doi: 10.1053/j.gastro.2017.04.022.
  • Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20(18):5191–204. doi: 10.3748/wjg.v20.i18.5191.
  • Nagy P, Johansson S, Molloy-Bland M. Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA. Gut Pathog. 2016;8:8. doi: 10.1186/s13099-016-0091-7.
  • Conwell DL, Lee LS, Yadav D, Longnecker DS, Miller FH, Mortele KJ, et al. American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines. Pancreas. 2014;43(8):1143–62. doi: 10.1097/MPA.0000000000000237.
  • Kalivarathan J, Yadav K, Bataller W, Brigle NW, Kanak MA. Etiopathogenesis and pathophysiology of chronic pancreatitis. Transplant, Bioengineering, Regeneration Endocr Pancreas. 2019;2:5–32. doi: 10.1016/B978-0-12-814831-0.00001-4.
  • Sankaran SJ, Xiao AY, Wu LM, Windsor JA, Forsmark CE, Petrov MS. Frequency of progression from acute to chronic pancreatitis and risk factors: a meta-analysis. Gastroenterology. 2015;149(6):1490–500. doi: 10.1053/j.gastro.2015.07.066.
  • DeSouza SV, Singh RG, Yoon HD, Murphy R, Plank LD, Petrov MS. Pancreas volume in health and disease: a systematic review and meta-analysis. Expert Rev Gastroenterol Hepatol. 2018;12(8):757–66. doi: 10.1080/17474124.2018.1496015.
  • Peery AF, Crockett SD, Murphy CC, Lund JL, Dellon ES, Williams JL, et al. Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018. Gastroenterol. 2019;156(1):254–72.e11. doi: 10.1053/j.gastro.2018.08.063.
  • Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, Whitcomb DC. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115(3):322–339. doi: 10.14309/ajg.0000000000000535.
  • Petrov MS, Yadav D. Global epidemiology and holistic prevention of pancreatitis. Nat Rev Gastroenterol Hepatol. 2019;16(3):175–84. doi: 10.1038/s41575-018-0087-5.
  • Olesen SS, Juel J, Nielsen AK, Frøkjær JB, Wilder-Smith OH, Drewes AM. Pain severity reduces life quality in chronic pancreatitis: Implications for design of future outcome trials. Pancreatology. 2014;14(6):497–502. doi: 10.1016/j.pan.2014.09.009.
  • Retnakumar RJ, Nath AN, Nair GB, Chattopadhyay S. Gastrointestinal microbiome in the context of Helicobacter pylori infection in stomach and gastroduodenal diseases. Prog Mol Biol Transl Sci. 2022;192(1):53–95. doi: 10.1016/bs.pmbts.2022.07.001.
  • Alexander SM, Retnakumar RJ, Chouhan D, Devi TNB, Dharmaseelan S, Devadas K, et al. Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes. Front Microbiol. 2021;12:713955. doi: 10.3389/fmicb.2021.713955.
  • Troncoso C, Pavez M, Cerda Á, Manríquez V, Prado A, Hofmann E, et al. Association of Progranulin Gene Expression from Dyspeptic Patients with Virulent Helicobacter pylori Strains; In Vivo Model. Microorganisms. 2022;10(5):998. doi: 10.3390/microorganisms10050998.
  • Bulajic M, Panic N, Löhr JM. Helicobacter pylori and pancreatic diseases. World J Gastrointest Pathophysiol. 2014;5(4):380–3. doi: 10.4291/wjgp.v5.i4.380.
  • Bai X, Zhu M, He Y, Wang T, Tian D, Shu J. The impacts of probiotics in eradication therapy of Helicobacter pylori. Arch Microbiol. 2022;204(12):692. doi: 10.1007/s00203-022-03314-w.
  • Wu X, Xu X, Xiang Y, Fan D, An Q, Yue G, et al. Exosome-mediated effects and applications in inflammatory diseases of the digestive system. Eur J Med Res. 2022;27(1):163. doi: 10.1186/s40001-022-00792-y.
  • Palmer B, Petrik M. Psychological Evaluation and Management of Chronic Pancreatitis. Gastroenterol Clin North Am. 2022;51(4):799–813. doi: 10.1016/j.gtc.2022.07.006.
  • Koch RM, Tchernodrinski S, Principe DR. Case report: Rapid onset, ischemic-type gastritis after initiating oral iron supplementation. Front Med (Lausanne). 2022;9:1010897. doi: 10.3389/fmed.2022.1010897.
  • Cañamares-Orbís P, García-Rayado G, Alfaro-Almajano E. Nutritional Support in Pancreatic Diseases. Nutrients. 2022;14(21):4570. doi: 10.3390/nu14214570.
  • Greer JB, Greer P, Sandhu BS, Alkaade S, Wilcox CM, Anderson MA, et al. Nutrition and Inflammatory Biomarkers in Chronic Pancreatitis Patients. Nutr Clin Pract. 2019;34(3):387–99. doi: 10.1002/ncp.10186.
  • Ahmed A, Anand AN, Shah I, Yakah W, Freedman SD, Thomas R, et al. Prospective evaluation of sleep disturbances in chronic pancreatitis and its impact on quality of life: a pilot study. Sleep Breath. 2022;26(4):1683–91. doi: 10.1007/s11325-021-02541-7.
  • Phillips AE, Faghih M, Drewes AM, Singh VK, Yadav D, Olesen SS, et al. Psychiatric Comorbidity in Patients With Chronic Pancreatitis Associates with Pain and Reduced Quality of Life. Am J Gastroenterol. 2020;115(12):2077–85. doi: 10.14309/ajg.0000000000000782.
  • Machicado JD, Amann ST, Anderson MA, Abberbock J, Sherman S, Conwell DL, et al. Quality of Life in Chronic Pancreatitis is Determined by Constant Pain, Disability/Unemployment, Current Smoking, and Associated Co-Morbidities. Am J Gastroenterol. 2017;112(4):633–42. doi: 10.1038/ajg.2017.42.